The FDA has granted Fast Track Designation to Lundbeck’s investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA).

Background Multiple system atrophy (MSA) is a progressive neurodegenerative disorder of unknown etiology, manifesting as combination of parkinsonism, cerebellar syndrome and dysautonomia.

After originally being dragged along with former Aggie head coach Jim Schlossnagle to Austin, Earley quickly found his way back to College Station last summer. Texas A&M Aggies left fielder Caden ...

Intravenous immunoglobulin (IVIG) has anti-inflammatory properties with multiple mechanisms of action. IVIG inhibits autoreactive T cells, suppresses autoantibodies through anti-idiotypic ...

The past year has been quite a hectic one for new Texas A&M head baseball coach Michael Earley. Earley came into the 2024 season as the hitting coach for the Maroon and White, who sported a ...

The lights inside Rudy’s Barbecue shone just a little brighter Thursday night, as Texas A&M head baseball coach Michael Earley took center stage on the Aggie Diamond Hour. It was a moment that ...

For part 3 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the favorable safety and efficacy profile of nipocalimab for generalized myasthenia gravis (gMG).

Alterity Therapeutics Limited (market cap: $40 million), a pharmaceutical company specializing in the development of therapeutic drugs, has secured A$40 million in funding to advance the development ...

Jan. 15, 2025 — New observational data and simulation models have confirmed a new type of planet unlike anything found in the Solar System. This provides another piece of the puzzle to ...

As of February 2025, Tony Romo is married to his wife, Candice Crawford Romo. According to People, Crawford is an American sports journalist. They got married in 2011 and have three sons named ...

For many years, IEEE multiple publication policy has established a useful standard for authors and publication volunteers. Authors should only submit original work that has neither appeared elsewhere ...

Astellas has suffered another major setback with geographic atrophy (GA) treatment Izervay, this time in the US. The company has received a complete response letter (CRL) from the FDA for a ...